BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34413681)

  • 1. Analysis of Factors Related to Lymph Node Metastasis in Early-Stage Type 1 Endometrial Cancer: Verifying the Clinical Value of Positive Threshold of the Immunohistochemical Parameter Ki67.
    Jiang P; Yuan R
    Cancer Manag Res; 2021; 13():6319-6328. PubMed ID: 34413681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Clinicopathological Parameters and Molecular Indicators to Predict Lymph Node Metastasis in Endometrioid Type Endometrial Adenocarcinoma.
    Jiang P; Huang Y; Tu Y; Li N; Kong W; Di F; Jiang S; Zhang J; Yi Q; Yuan R
    Front Oncol; 2021; 11():682925. PubMed ID: 34422634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.
    Lei H; Xu S; Mao X; Chen X; Chen Y; Sun X; Sun P
    J Inflamm Res; 2021; 14():7131-7142. PubMed ID: 34992410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A nomogram for predicting lymph node metastasis in early gastric cancer].
    Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive Assessment of ERα, PR, Ki67, P53 to Predict the Risk of Lymph Node Metastasis in Low-Risk Endometrial Cancer.
    Huang Y; Jiang P; Kong W; Tu Y; Li N; Wang J; Zhou Q; Yuan R
    J Invest Surg; 2023 Dec; 36(1):2152508. PubMed ID: 36521837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive model for the preoperative assessment and prognostic modeling of lymph node metastasis in endometrial cancer.
    Asami Y; Hiranuma K; Takayanagi D; Matsuda M; Shimada Y; Kato MK; Kuno I; Murakami N; Komatsu M; Hamamoto R; Kohno T; Sekizawa A; Matsumoto K; Kato T; Yoshida H; Shiraishi K
    Sci Rep; 2022 Nov; 12(1):19004. PubMed ID: 36347927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of indicator of CA125 combined with D-dimer (ICD) for lymph node metastasis in patients with ovarian cancer: A two center cohort study.
    Zhang L; Guan Z; Yin Y; Ou C; Qian H; Tang M; Shen A
    J Cancer; 2022; 13(8):2447-2456. PubMed ID: 35711840
    [No Abstract]   [Full Text] [Related]  

  • 9. Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer.
    Fasmer KE; Gulati A; Dybvik JA; Ytre-Hauge S; Salvesen Ø; Trovik J; Krakstad C; Haldorsen IS
    Eur Radiol; 2020 May; 30(5):2443-2453. PubMed ID: 32034487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.
    Hsiao YY; Fu HC; Wu CH; Lan J; Ou YC; Tsai CC; Lin H
    Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
    Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification.
    Zhang Y; Zhao W; Chen Z; Zhao X; Ren P; Zhu M
    J Obstet Gynaecol Res; 2020 Nov; 46(11):2305-2313. PubMed ID: 32844525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
    Miller HA; Tran A; LyBarger KS; Frieboes HB
    Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of S100A9 for lymph node metastasis in cervical cancer.
    Jiang Y; Wang Q; Xu Q; Zhang S; Cao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):701-708. PubMed ID: 32879128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor size measured by multidetector CT in resectable colon cancer: correlation with regional lymph node metastasis and N stage.
    Mou A; Li H; Chen XL; Fan YH; Pu H
    World J Surg Oncol; 2021 Jun; 19(1):179. PubMed ID: 34134714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-to-Lymphocyte Ratio Was an Independent Predictor of Lymph Node Metastasis in Patients with Clinically Node-Negative Advanced-Stage Gastric Cancer.
    Hu P; Wang W; He C
    Int J Gen Med; 2023; 16():1345-1354. PubMed ID: 37089136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Ki67 in Patients with Stage 1-2 Endometrial Cancer: Validation of the Cut-off Value of Ki67 as a Predictive Factor.
    Jiang P; Jia M; Hu J; Huang Z; Deng Y; Lai L; Ding S; Hu Z
    Onco Targets Ther; 2020; 13():10841-10850. PubMed ID: 33149602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.
    Feng X; Hong T; Liu W; Xu C; Li W; Yang B; Song Y; Li T; Li W; Zhou H; Yin C
    Front Endocrinol (Lausanne); 2022; 13():1054358. PubMed ID: 36465636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot Study to Establish a Novel Five-Gene Biomarker Panel for Predicting Lymph Node Metastasis in Patients With Early Stage Endometrial Cancer.
    Huang CY; Liao KW; Chou CH; Shrestha S; Yang CD; Chiew MY; Huang HT; Hong HC; Huang SH; Chang TH; Huang HD
    Front Oncol; 2019; 9():1508. PubMed ID: 32039004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.